Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 44, 2015 - Issue 4
173
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Meta-Analysis: The Relationship Between CTLA-4 +49 A/G Polymorphism and Primary Biliary Cirrhosis and Type I Autoimmune Hepatitis

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Nader Ali Ismail, Eman Ali Toraih, Hatem Mohamed Ameen, Amal Hussein Ahmed Gomaa & Radwa El- Sayed Mahmoud Marie. (2021) Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case–Control Study. Immunological Investigations 50:8, pages 977-986.
Read now
Yoshio Aizawa & Atsushi Hokari. (2017) Autoimmune hepatitis: current challenges and future prospects. Clinical and Experimental Gastroenterology 10, pages 9-18.
Read now

Articles from other publishers (18)

Rossella Fasano, Eleonora Malerba, Marcella Prete, Antonio Giovanni Solimando, Alessio Buonavoglia, Nicola Silvestris, Patrizia Leone & Vito Racanelli. (2022) Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis. Frontiers in Immunology 12.
Crossref
Tanuj Upadhyay & Shvetank Bhatt. 2022. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 93 119 .
Bastian Engel, Alena Laschtowitz, Maciej K. Janik, Norman Junge, Ulrich Baumann, Piotr Milkiewicz, Richard Taubert & Marcial Sebode. (2021) Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review. European Journal of Medical Genetics 64:6, pages 104214.
Crossref
Nawal S. Gouda, Manal S. Fawzy & Eman A. Toraih. (2021) Impact of cytotoxic T‐lymphocyte‐associated protein 4 codon 17 variant and expression on vitiligo risk. Journal of Clinical Laboratory Analysis 35:6.
Crossref
Takashi Higuchi, Shomi Oka, Hiroshi Furukawa, Shigeto Tohma, Hiroshi Yatsuhashi & Kiyoshi Migita. (2021) Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response. Human Genomics 15:1.
Crossref
Neil Halliday, Jessica Katharine Dyson, Douglas Thorburn, Ansgar W. Lohse & Michael A. Heneghan. (2020) Review article: experimental therapies in autoimmune hepatitis. Alimentary Pharmacology & Therapeutics.
Crossref
Petros Fessas, Lucia A. Possamai, James Clark, Ella Daniels, Cathrin Gudd, Benjamin H. Mullish, James L. Alexander & David J. Pinato. (2019) Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms. Immunology 159:2, pages 167-177.
Crossref
Elisabeth Sucher, Robert Sucher, Tanja Gradistanac, Gerald Brandacher, Stefan Schneeberger & Thomas Berg. (2019) Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies. Journal of Immunology Research 2019, pages 1-19.
Crossref
Chuan Huang, Hao-Xian Zhu, Yuan Yao, Zhen-Hua Bian, Yu-Jian Zheng, Liang Li, Haralampos M. Moutsopoulos, M. Eric Gershwin & Zhe-Xiong Lian. (2019) Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases. Journal of Autoimmunity 104, pages 102333.
Crossref
Rui Ling Chen, Qi Xia Wang & Xiong Ma. (2019) Precision medicine for autoimmune hepatitis. Journal of Digestive Diseases 20:7, pages 331-337.
Crossref
Annarosa Floreani, Paula Restrepo-Jiménez, Maria Francesca Secchi, Sara De Martin, Patrick S.C. Leung, Edward Krawitt, Christopher L. Bowlus, M. Eric Gershwin & Juan-Manuel Anaya. (2018) Etiopathogenesis of autoimmune hepatitis. Journal of Autoimmunity 95, pages 133-143.
Crossref
Ebrahim Eskandari-Nasab, Mehdi Moghadampour, Arezoo Tahmasebi & Abolghasem Asadi-Saghandi. (2018) Interleukin-17 A and F gene polymorphisms affect the risk of tuberculosis: An updated meta-analysis. Indian Journal of Tuberculosis 65:3, pages 200-207.
Crossref
Bao-Xin QianQing YeXin-Yu ZhaoTao HanFeng-Mei WangJie Yang. (2018) Meta-Analysis of the Relation Between IL10 Promoter Polymorphisms and Autoimmune Liver Disease Risk . Genetic Testing and Molecular Biomarkers 22:5, pages 302-313.
Crossref
Mingxue Wang & Hua Zhang. (2018) The pathogenesis of autoimmune hepatitis. Frontiers in Laboratory Medicine 2:1, pages 36-39.
Crossref
A. J. Czaja. (2017) Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 46:10, pages 920-937.
Crossref
Enbin Xu, Hailian Cao, Liming Lin & Honglong Liu. (2017) rs10499194 polymorphism in the tumor necrosis factor-α inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population. PLOS ONE 12:4, pages e0176471.
Crossref
Ebrahim Eskandari-NasabMehdi MoghadampourArezoo Tahmasebi. (2017) Meta-Analysis of Risk Association Between Interleukin-17A and F Gene Polymorphisms and Inflammatory Diseases. Journal of Interferon & Cytokine Research 37:4, pages 165-174.
Crossref
Xing-Chen Yang, Masayuki Fujino, Song-Jie Cai, Shao-Wei Li, Chi Liu & Xiao-Kang Li. (2017) Genetic Polymorphisms of Cytotoxic T-Lymphocyte Antigen 4 in Primary Biliary Cholangitis: A Meta-Analysis. Journal of Immunology Research 2017, pages 1-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.